Giorgia Marisi

ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 15

Top Topics

Chronic Kidney Disease

Metastatic Colorectal Cancer

Prognostic Factors

Top Venues

OncoTargets and therapy

Journal of clinical medicine

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Alessandro Passardi, Giorgia Marisi, Paola Ulivi
Metastatic Colorectal Cancer 2.0. Cancers 16 (12) (2024)
Francesco Giulio Sullo, Alessandro Passardi, Chiara Gallio, Chiara Molinari, Giorgia Marisi, Eleonora Pozzi, Leonardo Solaini, Alessandro Bittoni
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer. Journal of clinical medicine 13 (9) (2024)
Alessandro Passardi, Giorgia Marisi, Paola Ulivi
Metastatic Colorectal Cancer 2.0. Cancers 16 (12) (2024)
Francesco Giulio Sullo, Alessandro Passardi, Chiara Gallio, Chiara Molinari, Giorgia Marisi, Eleonora Pozzi, Leonardo Solaini, Alessandro Bittoni
Advancing Personalized Medicine in the Treatment of Locally Advanced Rectal Cancer. Journal of clinical medicine 13 (9) (2024)
Milena Urbini, Giorgia Marisi, Irene Azzali, Giulia Bartolini, Elisa Chiadini, Laura Capelli, Gianluca Tedaldi, Davide Angeli, Matteo Canale, Chiara Molinari, Francesca Rebuzzi, Alessandra Virga, Andrea Prochoswski Iamurri, Laura Matteucci, Francesco Giulio Sullo, Silvia Angela Debonis, Chiara Gallio, Giovanni Luca Frassineti, Giovanni Martinelli, Paola Ulivi, Alessandro Passardi
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer. JCO precision oncology 7 (2023)
Francesca Salani, Maryam Latarani, Stefano Cascinu, Priyadarsini Gangadharannambiar, Lorenzo Fornaro, Caterina Vivaldi, Irene Pecora, Valentina Massa, Giorgia Marisi, Matteo Canale, Paola Ulivi, Mario Scartozzi, Mark Eccleston, Gianluca Masi, Francesco Crea
Predictive significance of circulating histones in hepatocellular carcinoma patients treated with sorafenib. Epigenomics 14 (9) (2022)
Alessandro Passardi, Giorgia Marisi, Paola Ulivi
Metastatic Colorectal Cancer. Cancers 13 (24) (2021)
Ilario Giovanni Rapposelli, Serena De Matteis, Paola Lanuti, Martina Valgiusti, Giulia Bartolini, Paola Ulivi, Giorgia Marisi, Federica Pedica, Valentina Burgio, Giovanni Luca Frassineti, Stefano Cascinu, Stefano Cascinu
Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis. Cancers 13 (2) (2021)
Giulia Rovesti, Giorgia Marisi, Stefano Cascinu
Recent Research on Gastrointestinal Carcinoma. Cancers 13 (2) (2021)
Serena De Matteis, Martina Ghetti, Laura Gramantieri, Giorgia Marisi, Stefano Cascinu
Sorafenib in the Treatment of Virus-Related HCC: Differences Between HCV and HBV. OncoTargets and therapy 14 (2021)
Laura Marconato, Silvia Sabattini, Giorgia Marisi, Federica Rossi, Vito Ferdinando Leone, Andrea Casadei-Gardini
Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs. Cancers 12 (5) (2020)
Francesca Pirini, Luigi Pasini, Gianluca Tedaldi, Emanuela Scarpi, Giorgia Marisi, Chiara Molinari, Daniele Calistri, Alessandro Passardi, Paola Ulivi
Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients. International journal of molecular sciences 21 (10) (2020)
Stefano Cascinu, Laura Del Coco, Giorgia Marisi, Fabio Conti, Giulia Rovesti, Paola Ulivi, Matteo Canale, Giovanni Luca Frassineti, Francesco Giuseppe Foschi, Serena Longo, Francesco Paolo Fanizzi, Anna Maria Giudetti
1H-NMR Based Serum Metabolomics Highlights Different Specific Biomarkers between Early and Advanced Hepatocellular Carcinoma Stages. Cancers 12 (1) (2020)
Stefano Cascinu, Giorgia Marisi, Vincenzo Dadduzio, Laura Gramantieri, Luca Faloppi, Paola Ulivi, Francesco Giuseppe Foschi, Emiliano Tamburini, Caterina Vivaldi, Mario Domenico Rizzato, Luca Ielasi, Matteo Canale, Fabio Conti, Britt Rudnas, Lorenzo Fornaro, Nicola Silvestris, Marianna Silletta, Giovanni Gerardo Cardellino, Sara Lonardi, Francesca Fornari, Giulia Orsi, Giulia Rovesti, Vittorina Zagonel, Stefano Cascinu, Mario Scartozzi
Association of NOS3 and ANGPT2 Gene Polymorphisms with Survival in Patients with Hepatocellular Carcinoma Receiving Sorafenib: Results of the Multicenter Prospective INNOVATE Study. Clinical cancer research : an official journal of the American Association for Cancer Research 26 (17) (2020)
Stefano Cascinu, Marco Puzzoni, Francesco Montagnani, Giorgia Marisi, Emiliano Tamburini, Alessandro Cucchetti, Leonardo Solaini, Francesco Giuseppe Foschi, Fabio Conti, Giorgio Ercolani, Stefano Cascinu, Mario Scartozzi
Profile of lenvatinib in the treatment of hepatocellular carcinoma: design, development, potential place in therapy and network meta-analysis of hepatitis B and hepatitis C in all Phase III trials. OncoTargets and therapy 12 (2019)